> None of these require gain of function research. Please elaborate on this. How should I go about anticipating which mutations in which genes / protein will

> None of these require gain of function research. Please elaborate on this. How should I go about anticipating which mutations in which genes / protein will result in resistance to a candidate therapy / molecule / mechanism that I am considering advancing into phase 1 trials?